| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.1 |